Vasodilating β-adrenoceptor blockers as cardiovascular therapeutics
Author:
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 100 (3) , 215-234
Abstract
No abstract availableKeywords
This publication has 254 references indexed in Scilit:
- Short-term effect of ß-adrenoreceptor blocking agents on ocular blood flowCurrent Eye Research, 2001
- Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing ActionBiochemical and Biophysical Research Communications, 2001
- The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertensionBritish Journal of Clinical Pharmacology, 1999
- The β2-Adrenergic modulator celiprolol reduces insulin resistance in obese zucker ratsLife Sciences, 1999
- Carvedilol Inhibits Vascular Smooth Muscle Cell ProliferationJournal of Cardiovascular Pharmacology, 1993
- CeliprololDrugs, 1991
- Effects of Celiprolol on Systemic and Forearm Circulation in Hypertensive Patients: A Double‐Blind Cross‐Over Study Versus MetoprololThe Journal of Clinical Pharmacology, 1987
- Bevantolol: A Beta‐1 Adrenoceptor Antagonist with Unique Additional ActionsThe Journal of Clinical Pharmacology, 1987
- BetaxololDrugs, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980